Andrea Mariancini received his M.Sc. in Medical Biotecnology and Molecular Medicine at University of Milan (2017). After his graduation he worked as research fellow at Platform of Integrated Biology (IRCCS Isituto Nazionale Tumori, Milan). Starting from 2018 he joined the Laboratory of Experimental Immunophatology (Humanitas Research Hospital, Milan) and he obtained his PhD in Molecular and Experimental Medicine in 2023 under the supervision of Professor Cecilia Garlanda. His project is currently focused on elucidating the role of Interleukin 1 receptor type II (IL-1R2), the decoy receptor for Interleukin-1, in the immune system, particularly in the contest of cancer-related inflammation.